Literature DB >> 8195317

Molecular and genetic basis of X-linked immunodeficiency disorders.

J M Puck1.   

Abstract

Within a short time interval the specific gene defects causing three X-linked human immunodeficiencies, agammaglobulinemia (XLA), hyper-IgM syndrome (HIGM), and severe combined immunodeficiency (XSCID), have been identified. These represent the first human disease phenotypes associated with each of three gene families already recognized to be important in lymphocyte development and signaling: XLA is caused by mutations of a B cell-specific intracellular tyrosine kinase; HIGM, by mutations in the TNF-related CD40 ligand, through which T cells deliver helper signals by direct contact with B cell CD40; and XSCID, by mutations in the gamma chain of the lymphocyte receptor for IL-2. Each patient mutation analyzed to date has been unique, representing both a challenge for genetic diagnosis and management and an important resource for dissecting molecular domains and understanding the physiologic function of the gene products.

Entities:  

Mesh:

Year:  1994        PMID: 8195317     DOI: 10.1007/bf01541340

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  46 in total

1.  Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM.

Authors:  R Fuleihan; N Ramesh; R Loh; H Jabara; R S Rosen; T Chatila; S M Fu; I Stamenkovic; R S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

2.  Expression of the gene defect in X-linked agammaglobulinemia.

Authors:  M E Conley; P Brown; A R Pickard; R H Buckley; D S Miller; W H Raskind; J W Singer; P J Fialkow
Journal:  N Engl J Med       Date:  1986-08-28       Impact factor: 91.245

3.  Nonrandom X chromosome inactivation in B cells from carriers of X chromosome-linked severe combined immunodeficiency.

Authors:  M E Conley; A Lavoie; C Briggs; P Brown; C Guerra; J M Puck
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

4.  Refinement of linkage of human severe combined immunodeficiency (SCIDX1) to polymorphic markers in Xq13.

Authors:  J M Puck; M E Conley; L C Bailey
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

5.  Fine mapping of the human SCIDX1 locus at Xq12-13.1.

Authors:  S Markiewicz; J P DiSanto; J Chelly; N Fairweather; B Le Marec; C Griscelli; M B Graeber; U Müller; A Fischer; A P Monaco
Journal:  Hum Mol Genet       Date:  1993-06       Impact factor: 6.150

6.  Dinucleotide repeat polymorphism in the human CD40 ligand gene.

Authors:  R C Allen; M K Spriggs; J W Belmont
Journal:  Hum Mol Genet       Date:  1993-06       Impact factor: 6.150

7.  Long-term in vivo expression of a murine adenosine deaminase gene in rhesus monkey hematopoietic cells of multiple lineages after retroviral mediated gene transfer into CD34+ bone marrow cells.

Authors:  D M Bodine; T Moritz; R E Donahue; B D Luskey; S W Kessler; D I Martin; S H Orkin; A W Nienhuis; D A Williams
Journal:  Blood       Date:  1993-10-01       Impact factor: 22.113

8.  B lymphocyte precursors in human bone marrow: an analysis of normal individuals and patients with antibody-deficiency states.

Authors:  E R Pearl; L B Vogler; A J Okos; W M Crist; A R Lawton; M D Cooper
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

9.  CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM.

Authors:  J P DiSanto; J Y Bonnefoy; J F Gauchat; A Fischer; G de Saint Basile
Journal:  Nature       Date:  1993-02-11       Impact factor: 49.962

10.  Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor.

Authors:  S M Russell; A D Keegan; N Harada; Y Nakamura; M Noguchi; P Leland; M C Friedmann; A Miyajima; R K Puri; W E Paul
Journal:  Science       Date:  1993-12-17       Impact factor: 47.728

View more
  8 in total

1.  Maternal mosaicism for a novel interleukin-2 receptor gamma-chain mutation causing X-linked severe combined immunodeficiency in a Navajo kindred.

Authors:  A S O'Marcaigh; J M Puck; A E Pepper; K De Santes; M J Cowan
Journal:  J Clin Immunol       Date:  1997-01       Impact factor: 8.317

Review 2.  Gamma delta T-cell help in responses to pathogens and in the development of systemic autoimmunity.

Authors:  L Wen; A C Hayday
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

Review 3.  X-linked severe combined immunodeficiency disease and the gamma c receptor component: prospects for molecular diagnosis.

Authors:  N L Farner; S D Voss; P M Sondel
Journal:  Clin Diagn Lab Immunol       Date:  1995-09

Review 4.  Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: longterm outcomes.

Authors:  Rebecca H Buckley
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

5.  A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO).

Authors:  J Zonana; M E Elder; L C Schneider; S J Orlow; C Moss; M Golabi; S K Shapira; P A Farndon; D W Wara; S A Emmal; B M Ferguson
Journal:  Am J Hum Genet       Date:  2000-10-24       Impact factor: 11.025

6.  Intrinsic defect in B cells of patients with hyper-immunoglobulin M syndrome.

Authors:  Y B Porat; D Levy; J Levy; I Zan-Bar
Journal:  Clin Diagn Lab Immunol       Date:  1995-07

7.  Abnormal in vitro thymocyte differentiation in a patient with severe combined immunodeficiency-Nezelof's syndrome.

Authors:  A P Knutsen; D Wall; K R Mueller; J D Bouhasin
Journal:  J Clin Immunol       Date:  1996-05       Impact factor: 8.317

Review 8.  Advances in the understanding and treatment of human severe combined immunodeficiency.

Authors:  R H Buckley
Journal:  Immunol Res       Date:  2000       Impact factor: 4.505

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.